Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022

NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire

Spreading safe, cheap embolization around the world

Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice

R&D

Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.

Services

CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.

Training

Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.

Dernières Publications (5/479)

  1. Alavi, A, Revheim, ME, Newberg, AB, Werner, TJ, Guedj, E. 18F-Fluorodeoxyglucose PET, the Brain, and Other Organs: From the First Human Studies (1976) to 2026. PET Clin. 2026; :. doi: 10.1016/j.cpet.2026.05.001. PubMed PMID:42481350 .
  2. Berti, V, Fasciglione, E, Charpiot, A, Montanini, F, Pepponi, M, Leo, A et al.. Correction: Deciphering 18F-DOPA uptake in SDH-related head and neck paragangliomas: a radiomics approach. J Endocrinol Invest. 2026; :. doi: 10.1007/s40618-026-02985-2. PubMed PMID:42461578 .
  3. Sarrade, A, El Allam, J, Espinas, V, Hoffart, L, Picard, C, David, T et al.. Fast and compact scatterometer for ex vivo qualification of low-scattering biological samples. Rev Sci Instrum. 2026;97 (7):. doi: 10.1063/5.0327390. PubMed PMID:42439722 .
  4. Guedj, E, Beckman, D. Dopaminergic vulnerability in long COVID: striatal PET imaging at the brain-body interface. EBioMedicine. 2026; :106369. doi: 10.1016/j.ebiom.2026.106369. PubMed PMID:42431744 .
  5. Baboudjian, M, Barret, E, Brureau, L, Fiard, G, Fromont, G, Olivier, J et al.. Evidence thresholds for novel therapeutic strategies in prostate cancer: A consensus statement from the Prostate Cancer Committee of the French Urological Association. Fr J Urol. 2026;36 (9):103162. doi: 10.1016/j.fjurol.2026.103162. PubMed PMID:42413772 .
Search PubMed